Á lódáil...
Real-World Insight on Apremilast Therapy in Patients with Plaque Psoriasis: Indian Experience
INTRODUCTION: Psoriasis is an immune-mediated inflammatory skin disorder, which follows a chronic course. Apremilast is a novel phosphodiesterase 4 (PDE4) inhibitor, approved by US-FDA for the treatment of moderate to severe plaque psoriasis and psoriatic arthritis. A majority of the data related to...
Na minha lista:
| Foilsithe in: | Indian J Dermatol |
|---|---|
| Main Authors: | , , , |
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe: |
Wolters Kluwer - Medknow
2020
|
| Ábhair: | |
| Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7640799/ https://ncbi.nlm.nih.gov/pubmed/33165422 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/ijd.IJD_194_19 |
| Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|